openPR Logo
Press release

Primary Biliary Cholangitis Therapeutics Market Insights : Increase in Research and Development of Primary Biliary Cholangitis Therapeutics is Boosting the Market to Propel USD 1.4 Billion Revenue by 2032

04-18-2024 11:00 AM CET | Health & Medicine

Press release from: Allied Market Research

Primary Biliary Cholangitis Therapeutics Market Insights :

Allied Market Research published a report, titled, "Primary Biliary Cholangitis Therapeutics Market by Drug Type (Primary Drug and Secondary Drug), and Distribution Channel (Hospital Pharmacies, Drugs Stores and Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032" According to the report, the global primary biliary cholangitis therapeutics industry generated $0.68 billion in 2022 and is anticipated to generate $1.36 billion by 2032, witnessing a CAGR of 7.1% from 2023 to 2032.

The growth of the global primary biliary cholangitis therapeutics market is driven by increased awareness of the disease in developing countries, rising demand for corresponding treatments, and expanded research and development efforts. However, challenges such as delayed diagnosis and limited treatment options impede market growth. Conversely, opportunities for market expansion are anticipated through the adoption of key strategies by major industry players and the escalation of clinical trials investigating drugs for primary biliary cholangitis treatment.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/A108539

The primary drug segment dominated the global primary biliary cholangitis therapeutics market in 2022, representing over four-fifths of the revenue. It is expected to maintain its leading position throughout the forecast period due to the increasing adoption of primary drugs for treating primary biliary cholangitis (PBC). This segment is also projected to exhibit the highest compound annual growth rate (CAGR) of 7.3% from 2023 to 2032. This growth can be attributed to the intensified research and development efforts focused on primary drugs and their high effectiveness against PBC.

In 2022, North America emerged as the region with the highest revenue share in the global primary biliary cholangitis therapeutics market, capturing over two-fifths of the market revenue. This was attributed to its robust healthcare infrastructure, the presence of key industry players, and an increase in healthcare spending. However, the Asia-Pacific region is anticipated to experience the fastest compound annual growth rate (CAGR) of 8.5% from 2023 to 2032. It is expected to lead the market during the forecast period due to a surge in primary biliary cholangitis cases, unmet medical needs, and a large population base.

๐‹๐ž๐š๐๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ: -
ABC Farmaceutici S.p.a.
Alkem Laboratories Limited
AMAGEN INDIA LIFE SCIENCES
GENFIT
Intercept Pharmaceuticals, Inc.
Ipsen Pharma
Leeford Healthcare Ltd
Lupin
Sun Pharmaceutical Industries Ltd.
Zydus Lifesciences Limited

The report provides a detailed analysis of these key players in the global primary biliary cholangitis therapeutics market. These players have adopted different strategies such as acquisition, product launch, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

๐‘๐ž๐œ๐ž๐ง๐ญ ๐€๐ ๐ซ๐ž๐ž๐ฆ๐ž๐ง๐ญ ๐ข๐ง ๐ญ๐ก๐ž ๐๐ซ๐ข๐ฆ๐š๐ซ๐ฒ ๐๐ข๐ฅ๐ข๐š๐ซ๐ฒ ๐‚๐ก๐จ๐ฅ๐š๐ง๐ ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

In May 2022, Intercept Pharmaceuticals, Inc. announced that it has entered into an agreement to sell to Advanz Pharma, a pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals in Europe, certain foreign subsidiaries and rights regarding Intercept's international operations, including a license to commercialize Ocaliva (obeticholic acid) outside of the U.S.

๐’๐ฉ๐ž๐š๐ค ๐ญ๐จ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ-https://www.alliedmarketresearch.com/connect-to-analyst/A108539

๐‘๐ž๐œ๐ž๐ง๐ญ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐€๐ฉ๐ฉ๐ซ๐จ๐ฏ๐š๐ฅ ๐ข๐ง ๐ญ๐ก๐ž ๐๐ซ๐ข๐ฆ๐š๐ซ๐ฒ ๐๐ข๐ฅ๐ข๐š๐ซ๐ฒ ๐‚๐ก๐จ๐ฅ๐š๐ง๐ ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Obeticholic Acid Tablets, 5mg and 10mg, a generic equivalent of Ocaliva Tablets, 5 mg, and 10 mg, of Intercept Pharmaceuticals, Inc. This product will be manufactured at Lupin's Nagpur facility in India.

๐‘๐ž๐œ๐ž๐ง๐ญ ๐๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐ข๐ง ๐ญ๐ก๐ž ๐๐ซ๐ข๐ฆ๐š๐ซ๐ฒ ๐๐ข๐ฅ๐ข๐š๐ซ๐ฒ ๐‚๐ก๐จ๐ฅ๐š๐ง๐ ๐ข๐ญ๐ข๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

In December 2021, Ipsen and Genfit have entered a long-term strategic partnership in which Genfit has given Ipsen exclusive worldwide license to develop, manufacture, and commercialize its experimental late-stage treatment elafibranor, for people living with primary biliary cholangitis. The partnership also gives Ipsen access to future clinical programs led by Genfit and combines scientific expertise and proprietary technologies in liver disease of Genfit with development and commercialization capabilities of Ipsen.

๐Š๐ž๐ฒ ๐Ÿ๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฌ๐ญ๐ฎ๐๐ฒ

On the basis of drug type, the primary drug segment held the largest share in the primary biliary cholangitis therapeutics market analysis in 2022.

On the basis of distribution channel, the drugs stores and retail pharmacies dominated the market in 2022.

On the basis of region, Asia-Pacific is expected to witness the highest CAGR during the forecast period.

๐Š๐ง๐จ๐ฐ ๐Œ๐จ๐ซ๐ž- https://www.alliedmarketresearch.com/primary-biliary-cholangitis-pbc-therapeutics-market-A108539

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Primary Biliary Cholangitis Therapeutics Market Insights : Increase in Research and Development of Primary Biliary Cholangitis Therapeutics is Boosting the Market to Propel USD 1.4 Billion Revenue by 2032 here

News-ID: 3468507 • Views: โ€ฆ

More Releases from Allied Market Research

Pet Travel Services Market is projected to attain $1315.3 million by 2031, with a compound annual growth rate (CAGR) of 5.4% from 2022 to 2031
Pet Travel Services Market is projected to attain $1315.3 million by 2031, with โ€ฆ
Pet owners are spending a lot on their pets, and they are treating them as important family member. Pet owners are not only spending on grooming activities but also spending on pet holidays to provide them with a luxurious lifestyle. The increase in disposable income of pet owners is one of the most important factors that pulls the market growth. According to a new report published by Allied Market Research, titled,โ€ฆ
Travel Accessories is expected to Accumulated a Value of $95.7 billion By registering a CARG of 6.4% in the Forecast Period 2021-2031
Travel Accessories is expected to Accumulated a Value of $95.7 billion By regist โ€ฆ
According to a new report published by Allied Market Research, titled, "Travel Accessories Market," The travel accessories market was valued at $48.2 billion in 2021, and is estimated to reach $95.7 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. Travel accessories are products that are used during journey, which can be for various purposes, including business and leisure travel. People usually buy travel accessory products toโ€ฆ
U.S. corporate event market is anticipated to reach $510.9 billion by 2030, with a compound annual growth rate (CAGR) of 17.3% from 2021 to 2030
U.S. corporate event market is anticipated to reach $510.9 billion by 2030, with โ€ฆ
Tourism industry players focus on five key areas. These include encouraging high-quality tourism experiences, including indigenous tourism, limiting regulatory burden on industry, undertaking marketing campaigns, and working with industry to support the development of tourism infrastructure to drive the demand.According to a new report published by Allied Market Research, titled, "U.S. corporate event market by event type and industry: global opportunity analysis and industry forecast, 2021-2030," the U.S. corporate eventโ€ฆ
Bathroom vanities market is expected to achieve incremental growth, with a projected compound annual growth rate (CAGR) of 5.6%, surpassing $18.4 billion by the end of the period from 2021 to 2031
Bathroom vanities market is expected to achieve incremental growth, with a proje โ€ฆ
According to a new report published by Allied Market Research, titled, "Bathroom Vanities Market," The bathroom vanities market was valued at $10.2 billion in 2021, and is estimated to reach $18.4 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Bathroom vanities are pieces of bathroom furniture that include a sink on top of it or on the surface of the counter and storage areas around theโ€ฆ

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl โ€ฆ
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@โ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar โ€ฆ
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Reportโ€ฆ
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi โ€ฆ
Los Angeles, United State, June 11, 2019, -ย The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamideโ€ฆ
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene โ€ฆ
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applicationsโ€ฆ